Health giant Johnson & Johnson (J&J) is in discussions to acquire Swiss surgical products and medical services group, Synthes, Financial Times reports. The sale may value Synthes at up to $20 billion.
Synthes’ Chairman, Hansjorg Wyss, owns 40% of the company, and his family’s trust owns an additional 8%, adds The Associated Press. Synthes’ operations are split between Pennsylvania and Switzerland and the deal, if signed, will add to J&J’s $61.5 billion in annual revenue.
Click here for the story from Financial Times.
Click here for additional coverage from The Associated Press.